Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

May 16, 2025

PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS

Exafield US, a healthcare market research company based in the USA, is conducting a study on visual impairments and would love to hear your opinions! We are seeking English-speaking individuals…

PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS

May 15, 2025

Living with GA: How patients in the US and Western Europe cope

Living with GA: How patients in the US and Western Europe cope Author(s): Lynda Charters Key Takeaways Geographic atrophy significantly impacts patients’ daily activities, independence, and mental health, necessitating coping…

Living with GA: How patients in the US and Western Europe cope

May 15, 2025

The eSight GO

By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association When we were at our recent in-person seminar in Denver, we had the opportunity to have a representative…

The eSight GO

May 15, 2025

Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD

By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association Photobiomodulation (PBM) is a new treatment that was recently approved (November 2024) by the United States Food &…

Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD

May 15, 2025

Your Gut and Your Eyes: How a Healthy Gut Microbiome Can Help Protect Your Vision

by Julie Poteet, OD, MS, CNS, FOWNS If you’re living with macular degeneration, you’ve likely heard about vitamins, antioxidants, and eating leafy greens to protect your eyes. But did you…

Your Gut and Your Eyes: How a Healthy Gut Microbiome Can Help Protect Your Vision

May 12, 2025

Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD

May 11, 2025, By Sydney M Crago Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation…

Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD

May 11, 2025

Happy Mother’s Day

Wishing all the moms a wonderful day.

Happy Mother’s Day

May 2, 2025

“The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration”

By: Tatjana Josifova a,*, Katarzyna Konieczka b,c, Andreas Sch€otzau d, Josef Flammer b a Eye Clinic Orasis, Department for Medical and Surgical Retina, Reinach, Switzerland b Department of Ophthalmology, University…

“The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration”

Apr 22, 2025

A Young Man with the Heart of Gold- Running for Rita- Update

                    Running for Rita update Maxim finished the Half Marathon in 1 hour and 49 minutes. “Race day was amazing—such a…

A Young Man with the Heart of Gold- Running for Rita- Update

Apr 22, 2025

Treating dry eye disease may reduce migraine severity

By: Moira Mahoney Fact checked by: Christine Klimanskis, ELS Key takeaways: Treatment with ocular lubricants reduced Headache Impact Test scores in adults with migraine and dry eye disease. No significant…

Treating dry eye disease may reduce migraine severity

Apr 17, 2025

One Day Only- Matters of Vision! 2025 Denver-Aurora, CO

Matters of Vision! 2025 Denver-Aurora, CO. The Macular Degeneration Association will host a Free educational program on Saturday, May 10th. Registration required- Call (855) 962-2852 to reserve your seat(s)- Limited…

One Day Only- Matters of Vision! 2025 Denver-Aurora, CO

Apr 17, 2025

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy

Author(s): Martin David Harp Key Takeaways Vantage Biosciences has begun a phase 2 trial for VX-01, targeting moderate to severe NPDR without CI-DME. The study is double masked, randomized, placebo…

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy

Apr 6, 2025

Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up

This is interesting and important. The bottom line: If you are getting treated for wet AMD and stop going to follow-ups, you are proven not to do as well as…

Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up

Mar 31, 2025

The Aira App: On Demand Expert Assistance

With the Aira app, people with vision loss connect to vetted, live, expertly trained assistants. Using the camera on your smartphone, they walk you through whatever task you’re struggling to…

The Aira App: On Demand Expert Assistance

Mar 26, 2025

Researchers develop eye drops that slow progressive vision loss in mice

March 24, 2025 By Jordana Joy, Associate Editor Researchers developed eye drop formulations 17-mer and H105A, both containing a short peptide, to administer to mice in the form of a drop…

Researchers develop eye drops that slow progressive vision loss in mice

Mar 24, 2025

Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management

Join Our FREE Webinar! Topic: Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management When: March 26, 2025, at 12 PM EDT Duration: 1 hour Learn how…

Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management

Mar 24, 2025

Retinal vein occlusion (RVO) patients to participate in a paid market research study

      Opinions Link Research is looking for retinal vein occlusion (RVO) patients to participate in a paid market research study, sharing their opinions on this condition and treatments taken…

Retinal vein occlusion (RVO) patients to participate in a paid market research study

Mar 24, 2025

Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED

March 20, 2025, By Jordana Joy, Associate Editor Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline in the severity of overall dry…

Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED

Mar 18, 2025

Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial

New Research Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain inChildren: A Randomized Double‑Blind Placebo‑Controlled Trial Karen A.  Hecht· Megha Marwah· Vincent Wood· Yasuhiro Nishida· Austin E. Bach· Jeffry…

Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial

Mar 18, 2025

Cigarette smoking linked to reduced choroidal vascularity

Author(s): Lynda Charters Key Takeaways Cigarette smoking significantly reduces choroidal vascularity, as indicated by a decreased choroidal vascularity index (CVI). Smoking increases oxidative stress, affecting vascular endothelium and reducing retinal…

Cigarette smoking linked to reduced choroidal vascularity

Mar 14, 2025

Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’

By Sarah Caesar | Fact-checked by Barbara Bekiesz | Published March 10, 2025 Industry Buzz “[It’s] important to consider gradually tapering patients onto these drugs. Slowly lowering blood sugar, rather than doing so rapidly, may help reduce…

Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’

Mar 14, 2025

Can Vitamins Help Slow Down Macular Degeneration?

Macular degeneration is a progressive eye condition that has no cure. In some cases, a specific combination of nutrients found in supplements called AREDS 2 can slow its progression. Age-related…

Can Vitamins Help Slow Down Macular Degeneration?

Mar 11, 2025

The human impact of geographic atrophy

Author(s): Ophthalmology Times Staff Reports Fact checked by: Sheryl Stevenson Key Takeaways GA significantly impacts patients’ independence, with many reducing activities like driving and hobbies, affecting their sense of self…

The human impact of geographic atrophy

Mar 10, 2025

Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD

Author(s): Martin David Harp Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette and is designed to be administered…

Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD

Mar 4, 2025

Astaxanthin (AstaReal®) Improved Acute andChronic Digital Eye Strain inChildren: ARandomized Double‑Blind Placebo‑Controlled Trial

“Our very own medical director, Dr. Jeffry Gerson, is involved with eyecare beyond macular degeneration.”  See the latest publication he has been working on: ABSTRACT Introduction: This study assessed the…

Astaxanthin (AstaReal®) Improved Acute andChronic Digital Eye Strain inChildren: ARandomized Double‑Blind Placebo‑Controlled Trial

Mar 4, 2025

GA lesion location plays role in vision-related quality of life

By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: Vision-related quality of life is primarily dependent on the eye with better vision. An analysis found the inner lower…

GA lesion location plays role in vision-related quality of life

Mar 4, 2025

Older patients with DME have weaker response to anti-VEGF treatment

By: Alex Young Fact checked by: Christine Klimanskis, ELS Key takeaways: Improvement in visual acuity and central subfield thickness from baseline decreased with older age. Weak treatment response in both…

Older patients with DME have weaker response to anti-VEGF treatment

Mar 3, 2025

“Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy”

Principal Investigator: Jeremiah Brown, Jr., MS, MD It is notable that the rate of progression of geographic atrophy varies amongst patients, amongst lesion types, and amongst lesion patterns.  Some patients are…

“Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy”

Mar 3, 2025

Food as medicine: The role of nutrition in eye health

March 3, 2025 By Carrie Roitstein, OD, cPNP, INHC Fact checked by Jordana Joy, Associate Editor Creating a healthier population will require extended efforts by optometrists. The idea of using food as…

Food as medicine: The role of nutrition in eye health

Feb 18, 2025

Moderate to severe obstructive sleep apnea tied to higher odds for neovascular AMD

By: Cassandra Jenkins Fact checked by: Heather Biele Key takeaways: Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD. Nocturnal hypoxia may be a…

Moderate to severe obstructive sleep apnea tied to higher odds for neovascular AMD

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.